Credit Agricole
YMAB

Credit Agricole’s Y-mAbs Therapeutics YMAB Stock Holding History

Credit Agricole’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,500
Closed -$118K – 745
2021
Q2 		$118K Hold
3,500
– – ﹤0.01% 413
2021
Q1 		$106K Buy
+3,500
New +$143K ﹤0.01% 388

Other funds holding YMAB

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Credit Agricole's YMAB Position: Q3 2021 in Review

Credit Agricole sold out of Y-mAbs Therapeutics (YMAB) in Q3 2021, closing a stake of 3,500 shares — an estimated $118K sold.

Credit Agricole first reported a position in YMAB in Q1 2021 and held it in 2 quarters. The position peaked at $118K in Q2 2021. 97 funds tracked by Wall St. Rank hold YMAB as of Q3 2021.

  • Credit Agricole reported no remaining Y-mAbs Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Credit Agricole sold 3,500 Y-mAbs Therapeutics shares in Q3 2021, an estimated $118K.
  • Credit Agricole first reported a position in Y-mAbs Therapeutics in Q1 2021 and held it in 2 quarters.
  • Credit Agricole's Y-mAbs Therapeutics position peaked at $118K in Q2 2021.
  • 97 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2021.

Based on Credit Agricole's 13F filing for Q3 2021, filed 15 Nov 2021.